McHugh Julie 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Ironwood (IRWD) Director Julie McHugh Receives Award, Sells Shares
What Happened
Director Julie McHugh received a grant of 63,481 restricted shares (reported as acquired at $0.00) and separately sold 21,571 shares in open-market transactions on June 16, 2026. The sale had a reported weighted-average price of $3.73, generating proceeds of approximately $80,460. The restricted stock grant vests in full on the date immediately preceding the next year’s annual meeting per the company policy.
Key Details
- Transaction dates: June 16, 2026 (both the grant and the sale). Filing date: June 17, 2026 (filed timely).
- Grant: 63,481 restricted shares, acquisition price $0.00 (award under director compensation policy).
- Sale: 21,571 shares disposed, weighted-average price $3.73, total proceeds ~$80,460. Sales occurred at prices ranging $3.66–$3.78 (reported as a weighted average).
- Vesting/plan note: Grant is subject to the Second Amended and Restated Non-employee Director Compensation Policy; vests in full the day before the next annual meeting (footnote F1).
- Trading plan: The sale was effected under a Rule 10b5-1 trading plan (footnote F2).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Filing timeliness: Filed the next day; appears timely (no late filing flag).
Context
Restricted stock grants (price $0) are compensation, not market purchases, and vest later per the policy. Sales executed under a pre-established 10b5-1 plan are pre-planned transactions and are generally viewed as routine rather than an ad hoc signal of sentiment. The sale was modest in size (≈$80k) relative to typical insider activity.
Insider Transaction Report
- Award
Class A Common Stock
[F1]2026-06-16+63,481→ 272,320 total - Sale
Class A Common Stock
[F2][F3]2026-06-16$3.73/sh−21,571$80,460→ 250,749 total
Footnotes (3)
- [F1]The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.66 to $3.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.